EUVIMEDEUVIMED entdecken
Crossref

Aldosterone Synthase Inhibitors for Treatment of Hypertension and Chronic Kidney Disease

Nasser Mikhail

Clinical Endocrinology and Metabolism · 05.02.2024 · 03 (01) · 01-05

DOI: 10.31579/2834-8761/040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology and Metabolism, online erschienen am 05.02.2024. Verfasst von Nasser Mikhail.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aldosterone excess is known to worsen hypertension and kidney function. Three selective aldosterone synthase inhibitors (ASIs) were evaluated in 3 phase 2 trials. In the first study, the ASI baxdrostat 2 mg orally once daily decreased systolic blood pressure (SBP) by 11.0 mmHg compared with placebo after 12 weeks in patients with treatment-resistant hypertension. In the second study including patients with uncontrolled hypertension, placebo-corrected reduction in SBP with lorundrostat 50 mg once daily was 9.6 mmHg after 8 weeks. Patients receiving thiazides and those with body mass index (BMI) > 30 kg/m2 had the optimum blood pressure (BP) response to lorundrostat, whereas plasma renin activity (PRA) did not affect the its antihypertensive potency. In the third trial including patients with chronic kidney disease (CKD), the ASI BI 690517 (10 mg once daily) decreased urinary albumin creatinine ratio (UACR) by 39% after 14 weeks compared with 3% reduction with placebo. Reduction in UACR was generally similar in presence or absence of concomitant treatment with empagliflozin. The 3 ASIs mildly decreased (by

Zitieren

APA

Mikhail, N. (2024). Aldosterone Synthase Inhibitors for Treatment of Hypertension and Chronic Kidney Disease. Clinical Endocrinology and Metabolism, 03(01), 01-05. https://doi.org/10.31579/2834-8761/040

Vancouver

Mikhail N. Aldosterone Synthase Inhibitors for Treatment of Hypertension and Chronic Kidney Disease. Clinical Endocrinology and Metabolism. 2024;03(01):01-05. doi:10.31579/2834-8761/040

BibTeX
@article{Mikhail2024,
  author = {Mikhail, Nasser},
  title = {Aldosterone Synthase Inhibitors for Treatment of Hypertension and Chronic Kidney Disease},
  journal = {Clinical Endocrinology and Metabolism},
  year = {2024},
  volume = {03},
  number = {01},
  pages = {01--05},
  doi = {10.31579/2834-8761/040}
}
Kostenlos starten →